Beyond supportive care, there are currently no proven therapeutic options for pneumonia due
to coronavirus disease (COVID-19), the infection caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2). Human convalescent plasma is an option for treatment of COVID-19
and will be available when sufficient numbers of people have recovered. Such persons should
have high titer neutralizing immunoglobulin-containing plasma.